![Teva Canada Announces the Launch of AJOVY™ For the Preventive Treatment of Migraine in Adults Who Have at Least Four Migraine Days Per Month | Business Wire Teva Canada Announces the Launch of AJOVY™ For the Preventive Treatment of Migraine in Adults Who Have at Least Four Migraine Days Per Month | Business Wire](https://mms.businesswire.com/media/20200429005090/en/713670/23/teva_RGB_JPEG.jpg)
Teva Canada Announces the Launch of AJOVY™ For the Preventive Treatment of Migraine in Adults Who Have at Least Four Migraine Days Per Month | Business Wire
Teva Pharmaceutical Industries Ltd. - Test, test, and test again. Lisa Cameron and the Quality team at Teva Canada have their eyes on every angle of product quality to ensure our medicines
![Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthma Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthma](https://mma.prnewswire.com/media/1305988/Teva_Canada_Teva_Canada_announces_availability_of_Aermony_RespiC.jpg?p=facebook)